Zometapine

In today's world, Zometapine is a topic that has gained great relevance and has become a matter of interest to both experts and the general public. Since its emergence, Zometapine has sparked constant debate, generating conflicting opinions and triggering a series of investigations and analyzes in various fields. This article aims to thoroughly address this topic and analyze its importance, impact and relevance in today's society. Along these lines, different perspectives and arguments related to Zometapine will be explored, in order to provide a broad and enriching vision of this issue that is so relevant today.

Zometapine
Identifiers
  • 4-(3-chlorophenyl)-1,3-dimethyl-6,7-dihydro-2H-pyrazolodiazepine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H15ClN4
Molar mass274.75 g·mol−1
3D model (JSmol)
  • Clc3cccc(C/2=N/CC/N=C1/N(N\C(=C1\2)C)C)c3
  • InChI=1S/C14H15ClN4/c1-9-12-13(10-4-3-5-11(15)8-10)16-6-7-17-14(12)19(2)18-9/h3-5,8,18H,6-7H2,1-2H3 ☒N
  • Key:CJGOZEVWXQGMCS-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Zometapine (CI-781) is an antidepressant drug which is a pyrazolodiazepine derivative. Its molecular structure closely resembles thienodiazepines and is unrelated to other antidepressant drug classes.

See also

References

  1. ^ Katz RJ (October 1984). "Effects of zometapine, a structurally novel antidepressant, in an animal model of depression". Pharmacology, Biochemistry, and Behavior. 21 (4): 487–90. doi:10.1016/s0091-3057(84)80027-1. PMID 6542226. S2CID 43507076.